Given that T cells in the localized tumor tissue as well as systemic peripheral blood play a pivotal and major role in regulation for anti-tumor immunity, we observed a trend of Foxp3/CD3 and Foxp3/CD8 ratios being higher in the high HLA-A expression group than in the low HLA-A expression group. Here, CD8A is linked to neoplasm.